Plant-made Hemophilia Therapy Shows Promise, Penn Study Finds

Katherine Unger Baillie | kbaillie@upenn.edu | 215-898-9194

Monday, February 13, 2017

 

People with hemophilia require regular infusions of clotting factor to prevent them from experiencing uncontrolled bleeding. But a significant fraction develop antibodies against the clotting factor, essentially experiencing an allergic reaction to the very treatment that can prolong their lives.

Biggest Stories to come out of Tech & Education in 2016

Penn's decision to stay the course, while making big moves -- Penn's influence and prominence in the region goes without saying, which is why the opening of its Pennovation Center at the Pennovation Works campus on Grays Ferry Avenue is so momentous. The anchor point fo the campus, which slowly opened over the fall and hosted a celebratory grand opening in October, is now home to scores of promising biomed, engineering, robotic, fabrication and tech startups in its meticulously designed, 58,000 square-foot space.